Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins: Neoplasms trials

The registry lists 25 Neoplasms studies with Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as lead sponsor. 0 are open to participants now and 10 have results posted.

Early Phase 1 1Phase 1 16Phase 2 5No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Improving Cancer On-treatment Symptom ManagementCompletedNCT04589247Results posted
• Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors (Cohort D)CompletedNCT04098068Phase 2Results posted
• Tailored Home-Based Exercise Program for Multiple Chronic ConditionsCompletedNCT03874754Not applicableResults posted
• A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic CancerCompletedNCT03535727Phase 1/2Results posted
• Nivolumab With Ipilimumab in Subjects With Neuroendocrine TumorsTerminatedNCT03420521Phase 2Results posted
• Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation ExposureTerminatedNCT02864316Phase 2Results posted
• Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3)CompletedNCT02354534Phase 1Results posted
• Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)CompletedNCT00988559Phase 1Results posted
• Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial NeoplasiaCompletedNCT00121173Phase 1/2Results posted
• Benzoylphenylurea in Treating Patients With Advanced Solid TumorsCompletedNCT00016354Phase 1Results posted
• Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal CancerWithdrawnNCT04799431Phase 1
• Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral NeuropathyCompletedNCT03909464
• Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3)CompletedNCT03792516Phase 1
• A Window of Opportunity Study to Investigate Mechanisms of Actions of Novel Therapeutic Agents in Patients With Resectable Solid Tumor MalignanciesTerminatedNCT03471286Phase 1
• Trial of Mistletoe Extract in Patients With Advanced Solid TumorsCompletedNCT03051477Phase 1
• SRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or SpineCompletedNCT02716948Phase 1
• Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain TumorsCompletedNCT02644291Phase 1
• Adoptive Immunotherapy With Activated Marrow Infiltrating Lymphocytes and Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Relapse of Hematologic Malignancies After Allogeneic Hematopoietic Cell TransplantationCompletedNCT02342613Phase 1
• A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive CancersCompletedNCT02188563Not applicable
• Screening for Early Pancreatic Neoplasia (Cancer of the Pancreas Screening or CAPS4 Study)CompletedNCT00714701
• Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerTerminatedNCT00499733Early Phase 1
• Sirolimus in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00368914Phase 1
• One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard TherapyTerminatedNCT00358397Phase 1
• UCN-01 and Irinotecan in Treating Patients With Advanced Solid TumorsCompletedNCT00047242Phase 1
• Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid TumorsCompletedNCT00007813Phase 1